Cargando…
Drug-Coated Balloon in Primary Percutaneous Coronary Intervention
According to the latest coronary interventional guidelines, a drug-eluting stent is the recommended reperfusion therapy in primary percutaneous coronary intervention (pPCI). However, deficiencies and defects, such as in-stent restenosis (ISR), incomplete stent apposition, stent thrombosis, reinfarct...
Autores principales: | Zhao, Hui, Miao, Runran, Lin, Fei, Zhao, Guoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317576/ https://www.ncbi.nlm.nih.gov/pubmed/37404481 http://dx.doi.org/10.1155/2023/5210808 |
Ejemplares similares
-
Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future?
por: Merinopoulos, Ioannis, et al.
Publicado: (2018) -
Risk Score for Prediction of Acute Kidney Injury in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Zhao, Hui, et al.
Publicado: (2022) -
Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review
por: Mohiaddin, Hasan, et al.
Publicado: (2018) -
Application of drug-coated balloon in coronary artery intervention: challenges and opportunities
por: GAO, Lei, et al.
Publicado: (2016) -
Short-term outcome of percutaneous coronary intervention with directional coronary atherectomy followed by drug-coated balloon: a preliminary report
por: Sato, Akihiko, et al.
Publicado: (2018)